Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 801 results for "genentech"

Gazyva Shown to Outperform Rituxan in Phase 3 Trial in Follicular Lymphoma Patients

Gazyva Shown to Outperform Rituxan in Phase 3 Trial in Follicu...

Patients with follicular lymphoma may soon have a new treatment option, as Genentech recently demonstrated that Gazyva (obinutuzumab) improved survival times without disease progression compared to standard treatment with Rituxan (rituximab). Data ..., 16 hours ago

106 images for genentech

BioSpace, 1 day ago
PR Newswire, 1 day ago
Business Insider Malaysia, 3 days ago
BioSpace, 1 day ago
Nasdaq, 5 days ago
Scrip Intelligence, 2 weeks ago
Scrip Intelligence, 2 weeks ago
Scrip Intelligence, 2 weeks ago
Scrip Intelligence, 2 weeks ago
HCPLive, 2 weeks ago

Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1)

Competing interests VS has received consulting fees from Abbvie, Amgen, Bristol-Myers Squibb, Celgene, Genentech/Roche, Janssen, Lilly, Merck, Novartis, Pfizer and UCB. PM has received research grants, consultation fees and/or speaking fees from ...
 Annals of Rheumatic Diseases22 hours ago


Crenezumab higher dose in CREAD Phase 3 Alzheimer's trial supported by exposure-response model Phase 1b dose-escalation study results support 60mg/kg dose in CREAD Phase 3 Lausanne, Switzerland, December 9, 2016 - AC Immune SA (NASDAQ: ACIU), a ...
 Stockwatch16 hours ago BRIEF-AC Immune partner Genentech presents important data on Alzheimer's Therapy Crenezumab  Business Insider15 hours ago
PR Newswire

Roche's Genentech taps A-lister Morgan Freeman for cancer PSA

Roche's Genentech and partner Stand Up ToCancer (SU2C) have enlisted one of Hollywood's most famous voices for a new cancer PSA . Actor Morgan Freeman, along with cancer survivor Tonya Peat, star in TV and print ads that celebrate the progress ...
 FiercePharma19 hours ago Morgan Freeman Joins Stand Up To Cancer And Genentech In New PSA  TickerTech.com1 day ago

Novimmune and Genentech enter exclusive licence agreement for rheumatoid arthritis drug

Swiss Biotech firm Novimmune has entered into an option and licence agreement with Roche company Genentech to develop and commercialise its anti-toll-like receptor 4 (TLR4) monoclonal antibody, NI-0101, to treat rheumatoid arthritis and other ...
 Pharmaceutical Technology3 days ago

Genentech's Ocrevus: Pioneering The Progressive MS Therapy Landscape

By John Crowley, Ph.D., Decision Resources Group The last 12 months have brought about sought-after breakthroughs in the treatment of underserved progressive multiple sclerosis (MS) patients, and a landmark approval for one new therapy — ...
 Pharmaceutical Online1 week ago

G1 Therapeutics and Genentech to evaluate Phase II lung cancer trial of tecentriq and trilaciclib

US-based clinical-stage oncology company G1 Therapeutics has collaborated with Genentech to conduct a Phase II clinical trial of tecentriq and trilaciclib to treat patients with small-cell lung cancer (SCLC) receiving chemotherapy. G1's ...
 Drug Development Technology3 days ago G1 Therapeutics to Evaluate Trilaciclib (G1T28) in Combination with Immune Checkpoint Inhibitor in Small-Cell Lung Cancer  Minyanville5 days ago Halozyme and Genentech to Collaborate on Clinical Cancer Trials  Bioscience Technology Online1 week ago Update: Eshelman-backed G1, Genetech to test combo cancer therapy  Local Tech Wire3 days ago

Dornase Alfa (Genentech's Pulmozyme) Used Successfully Off-Label For Alzheimer's

Roche ( OTCQX:RHHBY , OTCQX:RHHBF ) has a strong neuroscience pipeline that includes three Alzheimer's ("AD") drugs, but Dornase Alfa isn't listed as being researched for AD. Dornase alfa is a purified solution of recombinant human deoxyribonuclease ...
 Seeking Alpha1 week ago

Roche kooperiert mit Genfer Firma

Aargauer Zeitung , 06.12.2016 Die Roche-Tochter Genentech baut ihre Zusammenarbeit mit der Genfer Biotechfirma Novimmune aus. Die beiden Unternehmen haben ein Lizenzabkommen über einen Wirkstoff von Novimmune gegen rheumatoide Arthritis ...
 Swiss Biotech3 days ago Roche licenses Novimmune's...  European Biotechnology5 days ago Novimmune grants Genentech an exclusive option to license NI-0101, its anti-TLR4 monoclonal antibody for the treatment of rheumatoid arthritis  4 Traders5 days ago BRIEF-Novimmune grants Genentech exclusive option to license NI-0101  Reuters UK5 days ago

OncoMed says CMO Dupont has resigned and expects return to Genentech/Roche

OncoMed Pharmaceuticals Inc. ( OMED ) said early Monday that Chief Medical Officer Jakob Dupont had resigned, effective early 2017, and that he plans a return to Genentech/Roche (ROG.EB). The company said it has started a search for its next CMO.
 TD Ameritrade4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less